2026 ADA Guidelines Standards of Care in Diabetes: Pharmacological Management of Type 2 Diabetes Mellitus
VIOLET Study Summary: Real World Evaluation of Vildagliptin and Vildagliptin + Metformin in Type 2 Diabetes Patients (DRC 2025)
Use of extracorporeal circulation (ECLS/ECMO) for cardiac and circulatory failure -A clinical practice Guideline Level 3.
Biosimilars of low molecular weight heparins: Relevant background information for your drug formulary.
Risk factors for wound infection caused by Methicillin Resistant Staphylococcus aureus among hospitalized patients: a case control study from a tertiary care hospital in India.
